Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Real-time Estimate Cboe BZX Other stock markets 03:14:08 2024-04-19 pm EDT			5-day change	1st Jan Change
125.9 ^USD	+0.53%		+0.03%	+15.37%

02:55pm	Merck Says Health Canada Approved Keytruda Plus Fluoropyrimidine, Platinum-Containing-Chemotherapy for Gastric Cancer	MT
02:42pm	BMO Capital Adjusts Price Target on Merck & Company to $148 From $132	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BMO Capital Adjusts Price Target on Merck & Company to $148 From $132	08:42am	MT
Leerink Partners Raises Merck's Price Target to $134 From $129	07:41am	MT
Zacks Adjusts Price Target on Merck & Company to $132 From $128	Apr. 15	MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating	Apr. 08	MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating	Mar. 27	MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating	Mar. 27	MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103	Mar. 11	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
UBS Adjusts Merck & Co.'s Price Target to $148 From $135, Maintains Buy Rating	Feb. 02	MT
Wells Fargo Raises Merck's Price Target to $130 From $125, Maintains Equalweight Rating	Feb. 02	MT
Truist Securities Raises Merck's Price Target to $139 From $122, Maintains Buy Rating	Feb. 02	MT
Goldman Sachs Raises Merck's Price Target to $134 From $128, Maintains Buy Rating	Feb. 02	MT
Barclays Raises Merck's Price Target to $145 From $135, Keeps Overweight Rating	Feb. 02	MT
Jefferies Raises Merck's Price Target to $140 From $136, Keeps Buy Rating	Feb. 02	MT
Did you expect anything different?	Feb. 01
Futures climb following Wall St selloff after Fed holds rates steady	Feb. 01	RE
Deutsche Bank Adjusts Merck & Company Price Target to $135 From $115, Maintains Buy Rating	Jan. 29	MT
BofA Securities Raises Merck Price Target to $135 From $130, Maintains Buy Rating	Jan. 26	MT
Barclays Raises Merck's Price Target to $135 From $130, Maintains Overweight Rating	Jan. 23	MT
UBS Adjusts Merck & Company Price Target to $135 From $122, Maintains Buy Rating	Jan. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters